Press Releases

Flagship Pioneering and its portfolio companies make news because of their transformative approaches to solving global challenges. If you have needs beyond these resources, please contact press@flagshippioneering.com.

company

year

domain

Axcella Strengthens Executive Team with Key Addition and Promotion

Axcella Therapeutics 11.25.2019

Axcella Announces Issuance of Broad Patent Covering EMM Compositions

Axcella Therapeutics 11.20.2019

Axcella Enters into Collaboration with CYTOO to Explore Impact of Dysregulated Metabolism on Muscle Physiology

Axcella Therapeutics 10.23.2019

Axcella Provides Progress Updates for Liver Program Candidates AXA1125 and AXA1957

Axcella Therapeutics 10.07.2019

Axcella Health Inc. Announces Appointment of Catherine A. Sohn, Pharm. D. to its Board of Directors

Axcella Therapeutics 08.23.2019

Axcella Announces Publication of Data Describing Attenuation of Muscle Atrophy with AXA2678 in Short-Term Muscle Disuse Study

Axcella Therapeutics 07.31.2019

Data from Axcella’s AXA1125 Program Supports New Approach Leveraging Endogenous Metabolic Modulators to Reprogram Cellular Physiology

Axcella Therapeutics 11.12.2018

Axcella Appoints Stephen Mitchener, Pharmd, to Senior Vice President, Chief Business Officer

Axcella Therapeutics 10.22.2018

Axcella Welcomes William D. Baird, and Cristina M. Rondinone, Ph.D., to Board Of Directors

Axcella Therapeutics 06.27.2018

Axcella Appoints Bill Hinshaw as President and Chief Executive Officer

Axcella Therapeutics 05.31.2018

Loading